$ENDV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDONOVO THERAPEUTICS, INC.. Get notifications about new insider transactions in ENDONOVO THERAPEUTICS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 35 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 41 | 21,771,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 98 | 21,769,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 9 | 21,764,123 | 21.8 M to 21.8 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 20,000 | 376 | 21,763,623 | 21.7 M to 21.8 M (+0.09 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 94 | 21,743,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,738,623 | 21.7 M to 21.7 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 9 | 21,736,623 | 21.7 M to 21.7 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 188 | 21,736,123 | 21.7 M to 21.7 M (+0.05 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 93 | 21,726,123 | 21.7 M to 21.7 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 21 | 21,721,123 | 21.7 M to 21.7 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 311 | 21,720,123 | 21.7 M to 21.7 M (+0.07 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,705,123 | 21.7 M to 21.7 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 210 | 21,704,623 | 21.7 M to 21.7 M (+0.05 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 104 | 21,694,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 102 | 21,793,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 3,000 | 60 | 21,788,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,785,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 99 | 21,783,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 40 | 21,778,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 99 | 21,776,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 41 | 21,771,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 98 | 21,769,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 9 | 21,764,123 | 21.8 M to 21.8 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 20,000 | 376 | 21,763,623 | 21.7 M to 21.8 M (+0.09 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 94 | 21,743,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,738,623 | 21.7 M to 21.7 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 9 | 21,736,623 | 21.7 M to 21.7 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 188 | 21,736,123 | 21.7 M to 21.7 M (+0.05 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 93 | 21,726,123 | 21.7 M to 21.7 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 21 | 21,721,123 | 21.7 M to 21.7 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 311 | 21,720,123 | 21.7 M to 21.7 M (+0.07 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,705,123 | 21.7 M to 21.7 M (0.00 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 210 | 21,704,623 | 21.7 M to 21.7 M (+0.05 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 104 | 21,694,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 107 | 21,689,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 103 | 21,684,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 105 | 21,679,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 107 | 21,674,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 105 | 21,669,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 105 | 21,664,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 106 | 21,659,623 | 21.7 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 100 | 21,654,623 | 21.6 M to 21.7 M (+0.02 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,649,623 | 21.6 M to 21.6 M (0.00 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 50 | 1 | 21,649,123 | 21.6 M to 21.6 M (0.00 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 450 | 9 | 21,649,073 | 21.6 M to 21.6 M (0.00 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,648,623 | 21.6 M to 21.6 M (0.00 %) |
Mar 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 99 | 21,648,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,603,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 113 | 21,598,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,593,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 120 | 21,588,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 120 | 21,583,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,578,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,573,123 | 21.6 M to 21.6 M (+0.05 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,563,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 120 | 21,558,123 | 21.6 M to 21.6 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 230 | 21,553,123 | 21.5 M to 21.6 M (+0.05 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 46 | 21,543,123 | 21.5 M to 21.5 M (+0.01 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,541,123 | 21.5 M to 21.5 M (0.00 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 4,000 | 90 | 21,540,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,536,123 | 21.5 M to 21.5 M (0.00 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,535,123 | 21.5 M to 21.5 M (0.00 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 227 | 21,534,123 | 21.5 M to 21.5 M (+0.05 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 342 | 21,524,123 | 21.5 M to 21.5 M (+0.07 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 226 | 21,509,123 | 21.5 M to 21.5 M (+0.05 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 335 | 21,499,123 | 21.5 M to 21.5 M (+0.07 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,484,123 | 21.5 M to 21.5 M (0.00 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,483,123 | 21.5 M to 21.5 M (0.00 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,482,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,477,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,472,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,467,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,462,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,457,123 | 21.5 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,452,123 | 21.4 M to 21.5 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 233 | 21,447,123 | 21.4 M to 21.4 M (+0.05 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,437,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,432,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,427,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 111 | 21,422,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,417,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,412,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 111 | 21,407,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 109 | 21,402,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 219 | 21,397,123 | 21.4 M to 21.4 M (+0.05 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 219 | 21,387,123 | 21.4 M to 21.4 M (+0.05 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 109 | 21,377,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,372,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,367,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 112 | 21,362,123 | 21.4 M to 21.4 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,500 | 56 | 21,357,123 | 21.4 M to 21.4 M (+0.01 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 223 | 21,354,623 | 21.3 M to 21.4 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 335 | 21,344,623 | 21.3 M to 21.3 M (+0.07 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 223 | 21,329,623 | 21.3 M to 21.3 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 223 | 21,319,623 | 21.3 M to 21.3 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 333 | 21,309,623 | 21.3 M to 21.3 M (+0.07 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 222 | 21,294,623 | 21.3 M to 21.3 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 221 | 21,284,623 | 21.3 M to 21.3 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 221 | 21,274,623 | 21.3 M to 21.3 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,264,623 | 21.3 M to 21.3 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,259,623 | 21.3 M to 21.3 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,254,623 | 21.2 M to 21.3 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,244,623 | 21.2 M to 21.2 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,234,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,229,623 | 21.2 M to 21.2 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,219,623 | 21.2 M to 21.2 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,209,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 226 | 21,204,623 | 21.2 M to 21.2 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,194,193 | 21.2 M to 21.2 M (0.00 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 222 | 21,193,623 | 21.2 M to 21.2 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,183,623 | 21.2 M to 21.2 M (0.00 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,182,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,177,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,172,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,167,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 113 | 21,162,623 | 21.2 M to 21.2 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,157,623 | 21.1 M to 21.2 M (+0.05 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,147,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,500 | 58 | 21,142,623 | 21.1 M to 21.1 M (+0.01 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,500 | 58 | 21,140,123 | 21.1 M to 21.1 M (+0.01 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 111 | 21,137,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 22 | 21,132,623 | 21.1 M to 21.1 M (0.00 %) |
Feb 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 52 | 26,703,897 | 26.7 M to 26.7 M (+0.01 %) |
Feb 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 52 | 26,701,897 | 26.7 M to 26.7 M (+0.01 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 26 | 21,093,623 | 21.1 M to 21.1 M (0.00 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,092,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,087,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 129 | 21,087,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,082,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,077,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 127 | 21,072,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 127 | 21,067,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,062,623 | 21.1 M to 21.1 M (+0.02 %) |
Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 131 | 21,057,623 | 21.1 M to 21.1 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 26 | 21,052,623 | 21.1 M to 21.1 M (0.00 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 27 | 21,051,623 | 21.1 M to 21.1 M (0.00 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 135 | 21,050,623 | 21 M to 21.1 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 131 | 21,045,623 | 21 M to 21 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 135 | 21,040,623 | 21 M to 21 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 133 | 21,035,623 | 21 M to 21 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 135 | 21,030,623 | 21 M to 21 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 2,000 | 56 | 21,025,623 | 21 M to 21 M (+0.01 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 2,000 | 58 | 21,023,623 | 21 M to 21 M (+0.01 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 10,000 | 310 | 21,021,623 | 21 M to 21 M (+0.05 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 10,000 | 313 | 21,011,623 | 21 M to 21 M (+0.05 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 157 | 21,001,623 | 21 M to 21 M (+0.02 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 28 | 20,996,623 | 21 M to 21 M (0.00 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 28 | 20,995,623 | 21 M to 21 M (0.00 %) |
Jan 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 28 | 20,994,623 | 21 M to 21 M (0.00 %) |
Jan 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 10,000 | 288 | 20,993,623 | 21 M to 21 M (+0.05 %) |